Mrs Ann Yerburgh disposed of her entire shareholding of 3,673,860 shares in the Company by way of transfer on 18 July 2025, as a result of which she has no ongoing private holding in the Company.
Back to All News
All Market News
Other Market News
GSK – Bepirovirsen Update
AstraZeneca – Breztri Update
CQS New City High Yield Release Monthly Report
GSK – AnaptysBio Inc Litigation Update
Harworth and Microsoft Receive Resolution to Grant
AstraZeneca – Saphnelo Update
Sign up for our Stock News Highlights
Delivered to your inbox every Friday